PUMA BIOTECHNOLOGY INC
PBYI •
Buy Open
Signal type
Buy
Status
Open
Open Price
$7.85
Stop Loss
$7.31
Performance
-3.51%
Days Open
6
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 9, 2026
Open Price $7.85
Stop Loss $7.31
Timespan Day
Company Profile
Name PUMA BIOTECHNOLOGY INC
Ticker PBYI
Market Cap $170.26M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $7.57
List Date Mar 21, 2012
Description
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Website Open Company Website